Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-04-10 4:16 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Mossler Mark Chief Accounting Officer | 45,720 | $0 | 47,220 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 4:35 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 1,389 | $8.1 | 316,075 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 4:34 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Dubin Glenn Director | 1,358 | $8.1 | 812,682 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 4:33 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 1,697 | $8.1 | 23,632 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:28 pm | N/A 2032-01-02 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:28 pm | N/A 2032-01-02 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:26 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 212,950 | $0 | 212,950 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:26 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 212,950 | $0 | 212,950 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:24 pm | N/A 2031-01-10 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 170,500 | $0 | 170,500 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:24 pm | N/A 2031-01-10 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 170,500 | $0 | 170,500 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:21 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:21 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:19 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 174,850 | $0 | 174,850 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:19 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 174,850 | $0 | 174,850 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-15 6:18 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 6,560 | $7.9 | 210,741 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:08 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 568,900 | $0 | 682,801 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:08 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 202,000 | $0 | 263,300 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:07 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 1,735 | $6.53 | 175,051 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:07 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 150,100 | $0 | 175,051 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:05 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 1,735 | $6.53 | 175,051 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:05 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 150,100 | $0 | 175,051 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:04 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 2,255 | $6.53 | 251,921 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:04 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 150,100 | $0 | 251,921 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:03 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,735 | $6.53 | 175,130 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:03 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 150,100 | $0 | 175,130 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:02 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,301 | $6.53 | 247,339 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:02 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 202,000 | $0 | 247,339 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:12 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Dubin Glenn Director | 1,687 | $6.52 | 811,324 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 1,725 | $6.52 | 314,686 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:10 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 2,108 | $6.52 | 21,935 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 4:21 pm | N/A 2033-11-15 | C4 Therapeutics Inc. | CCCC | Hughes Owen Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:28 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 6,617 | $1.7 | 312,961 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:27 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Dubin Glenn Director | 6,470 | $1.7 | 809,637 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:26 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 8,089 | $1.7 | 19,827 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:24 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 489,600 | $0 | 489,600 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:23 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:23 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:23 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:22 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:21 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 136,000 | $0 | 157,640 (Direct) | View |
Ownership | 2023-09-19 7:20 pm | N/A 2033-07-02 | C4 Therapeutics Inc. | CCCC | Mossler Mark Chief Accounting Officer | 0 | $0 | 50,210 (Direct) | View |
Ownership | 2023-09-19 7:20 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 0 | $0 | 215,515 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:13 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 7,500 | $0 | 168,901 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 2,205 | $2.93 | 168,901 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:12 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 2,250 | $0 | 43,186 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:12 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 661 | $2.93 | 43,186 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:11 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer | 2,250 | $0 | 49,186 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer | 661 | $2.93 | 49,186 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:10 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 2,250 | $0 | 43,186 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:10 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 661 | $2.93 | 43,186 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:10 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 2,250 | $0 | 120,576 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:10 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer | 661 | $2.93 | 120,576 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:09 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 2,250 | $0 | 43,265 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:09 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 661 | $2.93 | 43,265 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:06 pm | N/A 2033-07-09 | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 337,300 | $0 | 337,300 (Direct) | View |